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ABSTRACT  
 
Bony metastases in patients with osteosarcoma are unusual and normally appear late in 
the course of the disease. We report our experience with eight such patients, four with 
solitary and four with multiple metastases. Those with solitary metastases were treated 
as new tumours with neoadjuvant chemotherapy and surgery. Three remain alive with 
no evidence of disease at 5, 7 and 8 years follow-up respectively. Histology and 
response to neoadjuvant chemotherapy was similar in both the primary and metastatic 
lesions and is a predictive factor of outcome. Those with multiple metastases were 
treated by palliative measures, and none survived. We conclude that resection of solitary 
metastases from osteosarcoma after neoadjuvant chemotherapy can be curative. 
 
 
 
RÉSUMÉ 
 
Les métastases osseuses chez les patients atteints d’ostéosarcome sont rares et 
n’apparaissent que tardivement dans l’évolution de la maladie. Nous rapportons notre 
expérience avec 8 patients, 4 ayant uniquement des métastases osseuses et 4 des 
métastases multiples. Ceux qui présentaient une seule métastase ont été traité comme 
une tumeur primitive avec chimiothérapie néoadjuvante et chirurgie. Trois d’entre eux 
sont encore vivants sans évidence de maladie après 5, 7 et 8 ans de suivi. L’histologie et 
la réponse à la chimiothérapie néoadjuvante ont été similaires tant pour la lésion 
primaire que pour les métastases. Les patients avec métastases multiples ont été traité 
avec des mesures palliatives. Aucun d’eux n’a survécu. On peut conclure que la 
résection de ces métastases après chimiothérapie néoadjuvante peut être utilisée avec 
une intention curative en cas de métastase osseuse unique. 
  
 
 
 
 
INTRODUCTION 
 
The dissemination of metastases from sarcoma of bone is usually haematogenous, and 
the most frequent site for metastases is the lung [1, 2]. Treatment of lung metastases by 
surgery may improve survival rates in these patients [5, 6, 8, 9]. Skeletal metastases are 
less common and usually develop later in the disease. The aim of this paper was to 
analyse treatment and its outcome for patients with bony metastases from osteosarcoma. 
 
 
 
PATIENTS AND METHODS 
 
We treated 183 patients with osteosarcoma at the University Clinic of Navarra between 
1979 and 2001, 136 of whom received the complete protocol of treatment, trying to 
save the limb in all cases [13, 14, 16]. Primary surgical procedure was conservative in 
all but one case, regardless of their Enneking staging. Patients with more than one bony 
lesion at the time of diagnosis (three cases) could be considered as having synchronous 
multifocal osteosarcoma rather than bony metastases and therefore were not included in 
this study. Patients with skip metastases at the time of diagnosis were also excluded. 
 
Eight patients presented with bony metastases during routine follow-up. Mean patient 
age was 15 (11–30) years. Primary tumour site was the femur (four cases), tibia (three 
cases) and humerus (one case). Histological subtype was osteoblastic (five cases), 
chondroblastic (two cases) and telangiectatic (one case). Bony metastases appeared at a 
mean of 30 (19–68) months after diagnosis of the primary tumour. Four were solitary 
bony metastases and four were multiple, or combined with lung metastases. Solitary 
metastases sites were distal femur (two cases), acetabulum (one case) and lumbar spine 
(one case). In all cases, the histology was the same as that of the primary lesion. 
 
 
 
RESULTS 
  
 
When there were multiple bony metastases, (four cases), palliative treatment was 
undertaken with chemotherapy. Unusual drugs were used in an attempt to control the 
disease, including radioactive strontium, topotecan and melphalan. Palliative surgery 
was undertaken for pain control in two cases, one involving the facial nerve and one the 
sciatic nerve. All patients died at a mean of 16 months after detection of the bony 
metastases. 
 
When solitary metastases were detected, a biopsy was performed and the treatment for 
the metastases was similar as that for the primary lesion, including neoadjuvant 
chemotherapy and surgery. The nature of the surgical procedure depended on the site of 
the lesion. 
1. A wide resection and reconstruction with composite allograft-prosthesis was 
undertaken for a metastasis in the knee. 
2. A marginal resection and reconstruction with intercalary allograft was 
undertaken for a metastasis in the distal contralateral femur. The resection was 
marginal in order to preserve the knee (Fig. 1). 
3. A marginal resection without reconstruction was undertaken for a metastasis in 
the acetabulum. 
4. An intralesional resection and spinal fusion was undertaken for a metastasis in 
the lumbar spine (Fig. 2). 
 
The response of the metastases to neoadjuvant chemotherapy was very similar to that of 
the primary lesions. Two patients had necrosis of more than 90% in both the primary 
tumour and the metastases, and the other two had a poor response. Three are alive with 
no evidence of disease at 5, 7 and 8 years respectively after the surgical treatment. The 
other died of the disease. Surprisingly, the only death was the case treated by a wide 
resection; however, this was a chondroblastic osteosarcoma and there was a poor 
response to chemotherapy in both primary and the metastatic lesions. 
 
  
DISCUSSION 
 
To the best of our knowledge, there are no previous reports on this aspect of the 
treatment for bony metastases of osteosarcoma. There are many reports concerning the 
incidence and treatment of pulmonary metastases from osteosarcoma, and the role of 
surgery in managing such patients has been extensively described [11, 12, 17]. 
 
Development of bony metastases in patients with osteosarcoma is rare [7, 19]. In our 
series, only eight of 183 patients with osteosarcoma developed bony metastases. The 
true incidence may be higher, as bony metastases may develop in the terminal stages of 
the disease after the development of lung metastases. Bony metastases appeared at a 
mean of 30 months after diagnosis of the primary lesion. A bone scan is performed 
routinely in patients with osteosarcoma before starting the treatment protocol in order to 
detect bony metastases or synchronous polystotic lesions. After finishing the entire 
treatment protocol 1 year after diagnosis, another bone scan is performed. We believe 
this second bone scan may not be necessary, as bony metastases – when they occur – 
appear some years later. No bony metastases were detected on routine follow-up bone 
scans. All bony metastases were diagnosed by clinical symptoms, imaging studies and a 
biopsy. The first symptom was pain, mainly at night, similar to that with the primary 
tumour. Special imaging studies should be undertaken when there are symptoms such as 
unexplained pain, inflammatory pain or neurological symptoms presenting several years 
after the completion of treatment. Lung metastases rarely may also occur after a 10-year 
disease-free interval. Half our cases had solitary bony metastases. It is difficult to 
explain how the tumour cells disseminated in cases of bony metastases without 
pulmonary involvement, as the lungs should act as a filter in the haematogenous 
dissemination of the tumour. It is important to confirm the suspected diagnosis of bony 
metastasis by biopsy. Bone necrosis, traumatic or stress lesions or other benign 
conditions can simulate bony metastases [3, 4, 10, 15, 18, 20, 21, 22]. Imaging 
techniques may not always be reliable, and the past history of an osteosarcoma invites 
the radiologist to over-diagnose possible metastatic lesions. A biopsy was performed in 
other cases of suspected bony metastasis and the diagnosis was not confirmed. 
 
Treatment of these lesions requires a multidisciplinary approach, and it may be difficult 
to decide on the most appropriate form of treatment. We have shown, however, that 
solitary bony metastases can be treated curatively. Three of four cases are alive with no 
evidence of disease at 5, 7 and 8 years after excision of the metastasis. Response of the 
metastatic lesion to neoadjuvant chemotherapy was similar to that of the primary 
tumour. Thus, in these cases, we have the advantage of knowing how the tumour will 
respond to chemotherapy before surgery is undertaken. Survival of this particular 
subgroup of patients with solitary bony metastases is similar to those in the entire series 
with osteosarcomas who completed the treatment protocol at our centre – a survival rate 
of 77% at 5 years [23]. 
 
The benefit of surgery for solitary bony metastases from other tumours, such as renal 
cell carcinoma, has been described. Baloch et al. [2] found that aggressive surgical 
management of patients with solitary metastases from renal cell carcinoma can produce 
good long-term results. Unfortunately, in the cases of multiple bony metastases, 
treatment could only delay the fatal outcome. 
 
In summary, the appearance of solitary bony metastases during the follow-up of patients 
with osteosarcoma does not imply a fatal outcome. Such metastases are rare, usually 
appear late, and we therefore recommend that patients with osteosarcoma should be 
followed for at least 10 years. 
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Figure 1 a) A 12-year-old girl affected by osteosarcoma in her right tibia, also 
involving the epiphysis. She was treated with intraarterial neoadjuvant chemotherapy, 
surgery and adjuvant chemotherapy. Three years after diagnosis, she developed a 
pulmonary metastases and a thoracotomy was performed. Six months later, a cerebral 
metastases was removed. Five years after diagnosis, a bone metastases was detected in 
the contralateral knee. This lesion did not cross the growth plate. b) After biopsy and 
intraarterial chemotherapy, the metastasis was removed. Reconstruction was carried out 
with an intercalary allograft. Five years after surgical procedure for the metastases, there 
is no evidence of disease. 
 
 
 
 
 
 
 
 
 
 
Figure 2 a) This patient was treated in 1990 for a telangiectatic osteosarcoma in the 
proximal tibia. After intraarterial chemotherapy, the tumour was removed, and the limb 
was reconstructed with a composite allograft prosthesis. b) Four years later, a bone 
metastases was detected in the fifth lumbar vertebrae without metastases of the lung.    
c) After neoadjuvant intraarterial chemotherapy, the metastases was partially excised 
and a vertebral fusion was carried out. The vertebral tumour showed 100% necrosis 
after neoadjuvant chemotherapy. Eight years later, the patient remains free of disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
